CytomX Therapeutics, Inc. (CTMX) Logo

    CytomX Therapeutics, Inc. (CTMX) symbol, logo with name and high resolution download options.

    Download LogoStock API
    CytomX Therapeutics, Inc. (CTMX) logo

    Sector

    Healthcare

    Industry

    Biotechnology

    Ticker

    CTMX

    Website

    cytomx.com

    About CytomX Therapeutics, Inc. (CTMX)

    CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the validation of targets for antibody-drug conjugates (ADCs), opening therapeutic window for novel T-cell engagers (TCEs) targeting solid tumors, and increasing the therapeutic index for immune modulators, such as cytokines; and PROBODY platform in preclinical research in areas outside of oncology. It also develops CX-904, a T-cell-engaging bispecific antibody targeting the epidermal growth factor receptor (EGFR) on tumor cells and the CD3 receptor on T cells; CX-2051, a conditionally activated ADC for optimizing the therapeutic index for EpCAM-expressing epithelial cancers, including colorectal cancer; and CX-801, an interferon alpha-2b PROBODY cytokine. In addition, the company’s development pipeline comprises CX-2029, a conditional activated ADC targeting CD71; and BMS-986288, a PROBODY version of non-fucosylated ipilimumab. It has strategic collaborations with Amgen, Astellas, Bristol Myers Squibb, Regeneron, and Moderna; and clinical trial collaboration and supply agreement with Merck for the evaluation of CX-801 in combination with anti-PD-1 therapy, KEYTRUDA (pembrolizumab). The company was founded in 2008 and is based in South San Francisco, California.

    ISIN: US23284F1057
    Ticker: 6C1
    Ticker: 6C1.DU
    Ticker: 6C1.F
    Ticker: 6C1.SW
    Ticker: A14158
    Ticker: CTMX

    Get CytomX Therapeutics, Inc. (CTMX) Logo via API

    Integrate this logo into your application with a single API call

    GET https://api.logostream.dev/stocks/symbol/CTMX?key=YOUR_API_KEY&variant=icon
    View Full Documentation

    Why Use Our Stock Logo API?

    Fast Delivery

    <100ms response time via global CDN

    Enterprise-Ready

    99.99% uptime SLA with GDPR compliance

    Multiple Formats

    SVG, PNG, WebP - scalable to any size

    400k+ Logos

    Stocks, ETFs, Crypto, Banks, and more

    Where to Use Stock Logos

    Trading Platforms

    Real-time stock displays with instant logo loading

    Portfolio Apps

    Visualize holdings with recognizable brand logos

    Financial Dashboards

    Enhance market data with company branding

    News & Research

    Illustrate articles with accurate company logos

    Frequently Asked Questions

    Use our Stock Logo API with the ticker symbol CTMX. Make a GET request to https://api.logostream.dev/stocks/symbol/CTMX?key=YOUR_API_KEY to receive the logo. You can also specify format (SVG, PNG, WebP) and size parameters.

    The CytomX Therapeutics, Inc. (CTMX) logo is available in SVG, PNG, WebP, and JPG formats. SVG is recommended for scalability. Use the format parameter to specify your preferred format, e.g., ?format=svg or ?format=png.

    With a logostream API subscription, you can use logos for display purposes in financial applications, trading platforms, dashboards, and portfolio trackers. The logos are provided for informational and display purposes within your application.

    Simply embed the API URL as an image source in your application. For example: <img src="https://api.logostream.dev/stocks/symbol/CTMX?key=YOUR_API_KEY" />. The API returns optimized images with proper caching headers for fast loading.

    Need Stock Logos for Your Application?

    Access 380,000+ company logos via our simple REST API. Perfect for trading platforms, portfolio apps, and financial dashboards.

    View DocumentationRequest API Key